Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
21m agoEpsium Enterprise Limited Files Annual Report on Form 20-F for Fiscal Year 2025
54m agoNewmark Names Jack Fuchs as President of Global Asset Services and Member of the Executive Committee
1h agoStop the Rail Merger Coalition Launches to Oppose Union Pacific-Norfolk Southern Merger
1h agoNorthEast Community Bancorp, Inc. Reports Results for the Three Months Ended March 31, 2026
1h agoBetter Home Equity Card Powered by Stripe Enables Easy Access to HELOC Funds and Introduces a Modern Access Layer Across the $21.4 Trillion Home Equity Market
Corbus Pharmaceuticals Holding logo

Corbus Pharmaceuticals Holding

About

Corbus Pharmaceuticals Holding (NASDAQ:CRBP) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
Apr 14 2026
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
Apr 7 2026
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
Mar 18 2026
Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit
Mar 9 2026
Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update

Financials

Revenue
$0
Market Cap
$179.85 M
EPS
-5.90

Community Chat

Ask AI

6ix6ix